Empowered Patient Podcast

Tomer Shussman, CEO of OneStep, is combining in-person physical therapy and in-person care with remote care to provide more accessible healthcare, improve clinical outcomes, and enable clinicians to generate additional revenue streams. The OneStep smartphone app continuously monitors how patients move and analyzes over 40 different gait parameters. Working with providers, such as physical therapy clinics and orthopedic surgeons, OneStep has entered into the orthotic and prosthetic fields, translating these parameters into actual clinical insights.

Tomer explains, "So the main two or three things we've launched in the last year was one, a fall risk model. So we are now able to tell the user whether they are at a fall risk. I think we're the first ones in the world that have a model that makes sense in the sense that we're not just telling you, "Hey. you are at a high risk of falling," but we're telling you, "The system has recognized that some of your gait parameters have shifted in a way that is associated with a higher risk of falling. So we see that you're taking 10% narrower steps and 15% shorter steps. You're spending a bit too much time on your left leg, and this all has been associated with a fall risk."

"We have developed similar programs for amputees in the field of prosthetics, supporting the fine-tuning of the prosthetics and making sure they're installed properly. We've done similar things for upper body and lower back pain, where providers use OneStep to help triage patients and understand which patients can be transitioned to remote care and which patients can't. This is what OneStep has been focused on in the last year."

@DigitalOneStep #OneStep #GaitAnalysis #FallRiskAssessment #HealthTech #RTM #ChoosePT #PhysicalTherapy #Telehealth #HealthCareInnovation #Prosthetics #Amputees

onestep.co

Listen to the podcast here

Tomer Shussman, CEO of OneStep, is combining in-person physical therapy and in-person care with remote care to provide more accessible healthcare, improve clinical outcomes, and enable clinicians to generate additional revenue streams. The OneStep smartphone app continuously monitors how patients move and analyzes over 40 different gait parameters. Working with providers, such as physical therapy clinics and orthopedic surgeons, OneStep has entered into the orthotic and prosthetic fields, translating these parameters into actual clinical insights.

Tomer explains, "So the main two or three things we've launched in the last year was one, a fall risk model. So we are now able to tell the user whether they are at a fall risk. I think we're the first ones in the world that have a model that makes sense in the sense that we're not just telling you, "Hey. you are at a high risk of falling," but we're telling you, "The system has recognized that some of your gait parameters have shifted in a way that is associated with a higher risk of falling. So we see that you're taking 10% narrower steps and 15% shorter steps. You're spending a bit too much time on your left leg, and this all has been associated with a fall risk."

"We have developed similar programs for amputees in the field of prosthetics, supporting the fine-tuning of the prosthetics and making sure they're installed properly. We've done similar things for upper body and lower back pain, where providers use OneStep to help triage patients and understand which patients can be transitioned to remote care and which patients can't. This is what OneStep has been focused on in the last year."

@DigitalOneStep #OneStep #GaitAnalysis #FallRiskAssessment #HealthTech #RTM #ChoosePT #PhysicalTherapy #Telehealth #HealthCareInnovation #Prosthetics #Amputees

onestep.co

Download the transcript here

Angie Franks is the CEO of ABOUT Healthcare, focusing on care orchestration for patients needing acute, post-acute, and transitional care. ABOUT works with healthcare systems to use technology to replace many phone calls and manual work to allow for a smoother process of identifying appropriate and available facilities. This approach also impacts networks of referral sources, making it easier for health systems to build stronger relationships with consistent processes and standards.

Angie explains, "When we're talking about a physician seeking the right setting of care for the patient, that process is filled with friction. It's filled with friction because when they're calling and contacting a facility, calling an inpatient facility to see if they can accept another patient, the people that are answering those calls don't have the information that they need at their fingertips to be able to make the decision."

"When we come in and help health systems put in place the right technology, what we're doing is changing the workflow. We put in place some best practices in terms of operational processes. Then we enable that with technology to structure a decision-making process so that the people that receive that call have all of the information they need to be able to make a decision and execute on that decision. This takes what can be a multi-hour process and turn that into something that is 15 to 30 minutes."

@ABOUT_est2005 #ABOUTHealth #CareOrchestration #PatientFlow #PatientOutcomes #CareNavigation #PatientTransfers #PatientAccess

abouthealthcare.com

Listen to the podcast here

Angie Franks is the CEO of ABOUT Healthcare, focusing on care orchestration for patients needing acute, post-acute, and transitional care. ABOUT works with healthcare systems to use technology to replace many phone calls and manual work to allow for a smoother process of identifying appropriate and available facilities. This approach also impacts networks of referral sources, making it easier for health systems to build stronger relationships with consistent processes and standards.

Angie explains, "When we're talking about a physician seeking the right setting of care for the patient, that process is filled with friction. It's filled with friction because when they're calling and contacting a facility, calling an inpatient facility to see if they can accept another patient, the people that are answering those calls don't have the information that they need at their fingertips to be able to make the decision."

"When we come in and help health systems put in place the right technology, what we're doing is changing the workflow. We put in place some best practices in terms of operational processes. Then we enable that with technology to structure a decision-making process so that the people that receive that call have all of the information they need to be able to make a decision and execute on that decision. This takes what can be a multi-hour process and turn that into something that is 15 to 30 minutes."

@ABOUT_est2005 #ABOUTHealth #CareOrchestration #PatientFlow #PatientOutcomes #CareNavigation #PatientTransfers #PatientAccess

abouthealthcare.com

Download the transcript here

Lauren Ohlsson is the lead of industry solutions for pharmaceutical and healthcare at VDX.tv, which partners with pharmaceutical marketing teams, healthcare advertisers, and media agencies to create video content that drives engagement with patients and healthcare personnel. They create custom interactive video ad units seen across Connected TVs, desktop computers, and mobile devices and targeted to the desired patients or providers. Using QR codes on CTV and OTT ads allows viewers to scan the code to get additional information quickly.

Lauren explains, "One of the specific propositions we add is that we focus on CTV and then extend that reach to the household after that. It's a unique way to start these conversations around the household because often there are caretakers, family members, and a lot of people involved in medical decisions, so that's one of the facets of what VDX.tv can do."

"We can do everything by targeting medical professionals by their NPI numbers. So if there's a specific chart list of doctors or medical professionals to reach, we can help do that. And then, we can target by conditions, so whether or not somebody has the probability of potentially having a medical condition, we can also reach them."

"The environment is unique because we can target potential and prospective patients and healthcare providers via CTV. And then, to have the conversation with the household, we're able to follow up on desktops. So if you're engaging in health content, we'll take health.com, for example, you can see our ads, our video ads, in that environment as well, and then the same on a mobile device."

"We know in pharma, the marketing teams are very focused on an omnichannel approach. We have an advantage in that we can reach people on their TVs, and then also on their mobile and desktop devices to make sure that we're distributing appropriate content to the right audiences."

#VDXtv #DTCAds #HCPAds #HealthCarePersonnelAds #CTV #OTT #PharmaceuticalAds #HealthcareAds #MobileAds #PatientEngagement

VDX.tv

Listen to the podcast here

Lauren Ohlsson is the lead of industry solutions for pharmaceutical and healthcare at VDX.tv, which partners with pharmaceutical marketing teams, healthcare advertisers, and media agencies to create video content that drives engagement with patients and healthcare personnel. They create custom interactive video ad units seen across Connected TVs, desktop computers, and mobile devices and targeted to the desired patients or providers. Using QR codes on CTV and OTT ads allows viewers to scan the code to get additional information quickly.

Lauren explains, "One of the specific propositions we add is that we focus on CTV and then extend that reach to the household after that. It's a unique way to start these conversations around the household because often there are caretakers, family members, and a lot of people involved in medical decisions, so that's one of the facets of what VDX.tv can do."

"We can do everything by targeting medical professionals by their NPI numbers. So if there's a specific chart list of doctors or medical professionals to reach, we can help do that. And then, we can target by conditions, so whether or not somebody has the probability of potentially having a medical condition, we can also reach them."

"The environment is unique because we can target potential and prospective patients and healthcare providers via CTV. And then, to have the conversation with the household, we're able to follow up on desktops. So if you're engaging in health content, we'll take health.com, for example, you can see our ads, our video ads, in that environment as well, and then the same on a mobile device."

"We know in pharma, the marketing teams are very focused on an omnichannel approach. We have an advantage in that we can reach people on their TVs, and then also on their mobile and desktop devices to make sure that we're distributing appropriate content to the right audiences."

#VDXtv #DTCAds #HCPAds #HealthCarePersonnelAds #CTV #OTT #PharmaceuticalAds #HealthcareAds #MobileAds #PatientEngagement

VDX.tv

Download the transcript here

Shane Bishop, the Founder and Chief Pharmacy Officer of Custom Health, aims for true medication adherence by providing multiple drugs in multi-dose strips in a manner that strongly encourages patients to stick with their medication regimen. Pharmacists and clinicians communicating with patients on a regular basis using a digital device gain a better understanding of side effects and other reasons people are not taking their medicine. A fully integrated medication management system makes an enormous difference in the quality of life, particularly for complex patients who require a wide variety of drugs.

Shane elaborates, "Now, where we differentiate ourselves from others that are trying to accomplish the same type of thing to drive medication adherence through different packaging formats, we have a medication dispensing device that sits in a patient home where it drives medication adherence by beeping, whistling and flashing at the time of administration."

"The patient touches the screen and out pops one of those multi-dose strip packages and relays that information live back to our pharmacies in our network, the pharmacies we own and operate, and our clinical pharmacist team where we have up to 500 clinical pharmacists at any given time to look at the data. We also drive patient-reported outcome data."

"Our device also connects to the peripheral devices via Bluetooth connection. We can actually look at the vital information driven from glucometers, blood pressure monitors, and weight scales."

#CustomHealth #HealthCare #DigitalHealth #MedicationAdherence #Pharmacy #HomeBasedCare #Technology

customhealth.com

Listen to the podcast here

Shane Bishop, the Founder and Chief Pharmacy Officer of Custom Health, aims for true medication adherence by providing multiple drugs in multi-dose strips in a manner that strongly encourages patients to stick with their medication regimen. Pharmacists and clinicians communicating with patients on a regular basis using a digital device gain a better understanding of side effects and other reasons people are not taking their medicine. A fully integrated medication management system makes an enormous difference in the quality of life, particularly for complex patients who require a wide variety of drugs.

Shane elaborates, "Now, where we differentiate ourselves from others that are trying to accomplish the same type of thing to drive medication adherence through different packaging formats, we have a medication dispensing device that sits in a patient home where it drives medication adherence by beeping, whistling and flashing at the time of administration."

"The patient touches the screen and out pops one of those multi-dose strip packages and relays that information live back to our pharmacies in our network, the pharmacies we own and operate, and our clinical pharmacist team where we have up to 500 clinical pharmacists at any given time to look at the data. We also drive patient-reported outcome data."

"Our device also connects to the peripheral devices via Bluetooth connection. We can actually look at the vital information driven from glucometers, blood pressure monitors, and weight scales."

#CustomHealth #HealthCare #DigitalHealth #MedicationAdherence #Pharmacy #HomeBasedCare #Technology

customhealth.com

Download the transcript here

Maria Zannes, Founder and CEO of bioAffinity Technologies, has developed a noninvasive diagnostic test to screen for early-stage lung cancer. The test uses porphyrin to label cells to find cell populations with cancer cells. Using mucus from the lungs, this is a second test for people who are at high risk, giving them a chance to avoid more invasive procedures to determine their risk level and if they have lung cancer.

Maria explains, "The combination of being able to determine that cancer is present in the lungs with our test, coupled with the noninvasive nature of the test itself really spoke to me. Having a test for early detection of lung cancer where the treatment can be so much more effective and people can live so much longer and healthier lives is compelling."

"It's very simple for the patient and the doctor. The patient would go in, let's say they had a positive low-dose CT, they weren't sure, and the physician would then give the patient a small box. It's a 5x5 box with a little collection cup inside. We have a patient coach, an individual who calls the patient, and helps them to provide a sample, often early in the morning. People out of a shower start to cough up a little bit of mucus."

"The results tell the physician whether the patient is at high risk or has lung cancer or does not, but also gives them a numerical score, so the physician himself or herself has a little bit more to go on than just a yes or no answer."

@bioAffinity #LungCancer #CancerDiagnostic #Medtech #Biotech #CancerTreatment #CancerDiagnosis

bioaffinitytech.com

Listen to the podcast here

Maria Zannes, Founder and CEO of bioAffinity Technologies, has developed a noninvasive diagnostic test to screen for early-stage lung cancer. The test uses porphyrin to label cells to find cell populations with cancer cells. Using mucus from the lungs, this is a second test for people who are at high risk, giving them a chance to avoid more invasive procedures to determine their risk level and if they have lung cancer.

Maria explains, "The combination of being able to determine that cancer is present in the lungs with our test, coupled with the noninvasive nature of the test itself really spoke to me. Having a test for early detection of lung cancer where the treatment can be so much more effective and people can live so much longer and healthier lives is compelling."

"It's very simple for the patient and the doctor. The patient would go in, let's say they had a positive low-dose CT, they weren't sure, and the physician would then give the patient a small box. It's a 5x5 box with a little collection cup inside. We have a patient coach, an individual who calls the patient, and helps them to provide a sample, often early in the morning. People out of a shower start to cough up a little bit of mucus."

"The results tell the physician whether the patient is at high risk or has lung cancer or does not, but also gives them a numerical score, so the physician himself or herself has a little bit more to go on than just a yes or no answer."

@bioAffinity #LungCancer #CancerDiagnostic #Medtech #Biotech #CancerTreatment #CancerDiagnosis

bioaffinitytech.com

Download the transcript here